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Abstract: Dihydronaphthalenes (1a-d) were oxyarylated with o-
iodophenols (3a-d), in PEG-400 at 140 ºC or 170 ºC, leading regio- 
and stereoselectively to 5-carbapterocarpans (5). Using Pd(OAc)2 
(5-10 mol%) as pre-catalyst and Ag2CO3 (1.1 equiv) as base (Con-
ditions A), products were obtained in good to excellent chemical 
yields, in only 5-30 min of reaction, despite of the pattern of substi-
tution in 1 and 3. Alternatively, when p-hydroxyacetophenone 
oxime-derived palladacycle  (1 mol%) was used as pre-catalyst and 
dicyclohexylamine (2 equiv) as base (silver-free, Conditions B), 
adducts 5 were obtained from moderate to good yields, in 30 min 
to 4 h of reaction. Finally, the oxyarylation of dihydronaphthalens 
(1) and chromenquinone (2)  with 3a-d and 4 in PEG-400 under 
conditions A led regio- and stereoselectively to pterocarpanqui-
nones 6 and 7 in moderate yield  
Key words: oxyarylation reaction, PEG-400, 5-carba-
pterocarpans, pterocarpanquinones, PEG. 
 
 
In 1976 Horino and Inoue reported the synthesis of pterocarpin 
through a new regio and cis-stereoselective oxyarylation of 3-
methoxy-2H-1-chromene with o-chloromercurysesamol.1 In spite 
of the use of toxic o-mercuryphenols as intermediates and stoichi-
ometric amounts of PdCl2, the Inoue’s oxyarylation was further 
used in the synthesis of several naturally occurring pterocarpans, 
coumestans and derivatives.2  The first palladium catalyzed oxyary-
lation of 2H-1-chromens and dihydronaphthalenes with o-
iodophenols was reported by Larock et al, under neutral condi-
tions.3  The group of Antus4  also described the palladium catalyzed 
oxyarylation of 3-methoxy-2H-1-chromene with o-iodophenol in 
the presence of Ag2CO3 (cationic conditions). This oxyarylation 
was also investigated in our group and cationic intermediates were 
detected in EIS-MS.5  Optimize conditions were developed under 
MW heating, using both Pd(OAc)2 in acetone or p-
hydroxyacetophenone oxime-derived palladacycle in  DMA-H2O 
as pre-catalyst.6  New compounds with antineoplastic and antipara-
sitic properties were synthesized in our group by azaarylation and 
oxyarylation reaction but a restricted number of olefins were used 
in these studies.7   
In this paper we report the oxyarylation of olefins 1 and 2 with o-
iodophenols 3 and 3-iodolawsone (4) in PEG-400 as solvent (Fig-
ure  1) leading regio and stereoselectively to adducts 5, 6 and 7.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Olefins, o-iodophenols and adducts of oxyarylation 
studied in  this work. 
The 5-carbapterocarpans (5) are isosters8  of naturally occurring 
pterocarpans9 and can be used as a new scaffold to prepare bioac-
tive compounds.  The replacement of the oxygen atom in the B ring 
by a methylene in other groups of bioactive isoflavonoids (5-
carbapterocarpens and 1-carbaisoflavanones) has led to products 
with the same pharmacological profile.10 Carba-
pterocarpanquinones 6 and pterocarpanquinones 7, previously 
synthesized in our group, presented anti-neoplasic activity in hu-
Ligand Free Palladium-Catalyzed Oxyarylation of Dihydronaphthalens and 
Chromenequinone with o-Iodophenols and 3-Iodolawsone in PEG-400: An  
Efficient Synthesis of 5-Carba-Pterocarpans and Pterocarpanquinones 
Paula de Freitas de Moraesa, Francisco V. Gaspara,  Chaquip D. Nettob, Raquel A. C. Leãoa, Carmen Nájerac,       Pau-
lo R. R. Costaa*  
a
 Laboratório de Química Bioorgânica, Instituto de Pesquisas de Produtos 
Naturais, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, 
Bloco H, Ilha da Cidade Universitária, 21941-590, Rio de Janeiro, RJ, Brazil 
b
 Universidade Federal do Rio de Janeiro, Campus Macaé, Rio de Janeiro, RJ, 
Brazil 
c
 Departamento de Química Orgánica, Facultad de Ciencias and Centro de 
Innovación en Química Avanzada (ORFEO-CINQA), Universidad de Alicante, 
apdo. 99, 03080-Alicante, Spain 
Fax: +55-21-25626512 
E-mail: prrcosta2011@gmail.com 
Received: The date will be inserted once the manuscript is accepted.  
2 PSP  
Template for SYNLETT and SYNTHESIS © Thieme  Stuttgart · New York 2016-01-28 page 2 of 8 
O
H
H
I
HO
+
1a 3a 5aa
Pre-catalysts: Pd(OAc)2 or
Pd N OHCl
HO
2
  p-hydroxyacetophenone 
oxime-derived palladacycle
man cancer cell lines and antileishmanial activity in culture and in 
mice.7,17  
Looking for options to carry out oxyarylation reactions fast but 
under conventional heating, we envisaged that PEG could be used 
as solvent. PEG-400 has been used as a green solvent to accom-
plish palladium catalyzed Mizoroki-Heck and Stille reactions, 
Sonogashira and Suzuki-Miyaura cross-couplings.11  Moreover, 
Razler et al. showed that PEG-2000 promotes the formation of 
palladium nanoparticles, increasing the catalyst efficiency in the 
Suzuki-Miyaura reaction.12  The group of Corma reported a phos-
phine free highly active catalytic system for Suzuki and Sonogashi-
ra reactions13  in which an oxime palladacycle is anchored in chlo-
rinated PEG (PEG-PdL). More recently, palladacycles anchored to 
PEG has been used as a highly active catalytic system in Heck 
reactions.14 
Our first goal was optimize the oxyarylation of 1a with 3a leading 
to 5aa (Scheme 1, Table 1) in PEG. Razler et al. also demonstrated 
the formation of palladium nanoparticles on gelatin by the reduc-
tion of Pd2+ to Pd0, following by the disappearance of the absorp-
tion at 420 nm, associated with cationic palladium species.12  We 
also followed this reductive step by UV, heating the palladium 
source in PEG-400 at 140 ºC. Using Pd(OAc)2, we observed a total 
reduction of PdII to Pd0 in only 5 min, while 30 min are required for 
palladacycle. Based on these results and after some experimenta-
tion we chosed Pd(OAc)2 as pre-catalyst and Ag2CO3 as base, at 
140 ºC or 170  ºC (Conditions A). Alternatively, this oxyarylation 
was also evaluated using p-hydroxyacetophenone oxime-derived 
palladacycle as pre-catalyst, DIPEA as base in the absence of 
Ag2CO3 (Conditions B). The results obtained are shown in Scheme 
1, Table 1. The oxyarylation of 1a with 3a in the presence of 10 
mol% of Pd(OAc)2 and 1.5 equiv of Ag2CO3, in acetone under MW 
heating (60ºC, 40W), was used as reference and afforded the 5-
carbapterocarpan 5aa in 58% yield after 40 min of reaction (Table 
1, entry 1).6  When this reaction was performed in PEG-2000 and 
PEG-400 at 140 ºC (Conditions A), 1a was totally consumed in 40 
min and 2 h, respectively, giving 5aa in 87% and 45% yield, re-
spectively (Table 1, entries 2 and 3). The efficiency in PEG-400 
could be improved performing the reaction at 170 ºC, giving 5aa in 
87% yield in only 10 min (Table 1, entry 4). However, in PEG-200 
the oxyarylation reaction failed (Table 1, entry 5). Adduct 5aa was 
obtained in a similar yield using 5 mol% of Pd(OAc)2 in PEG-400 
at 170 ºC (Table 1, compare entries 4 and 6). In addition, in PEG-
400 it was possible to reduce the amount of Ag2CO3 from 1.5 equiv 
to 1.1 equiv, without affecting the chemical yield. 
The oxyarylation of 1a with 3a using 1 mol% of p-
hydroxyacetophenone oxime-derived palladacycle and 2.0 equiv of 
Cy2NH, in N,N-dimethylacetamide/water under MW heating 
(120ºC, 40W, 40 min) led to adduct 5aa in 41% yield (Table 1, 
entry 7). In PEG-2000 at 140 ºC the reaction was slower (3 h), 
product 5aa being obtained in 80% yield (Table 1, entry 8). How-
ever, in PEG-400 at 140 ºC no conversion was observed (data not 
shown), being necessary to increase the temperature to 170 ºC to 
get 5aa in 78% yield (Table 1, entry 10). 
While faster reactions and slightly better yields of 5aa were ob-
tained under Conditions A, under Conditions B the use of Ag2CO3 
is not required and in addition, a lower palladium loading was 
used. So, we decided to use both reaction conditions in the study of 
the scope of this reaction. 
Dihydronaphthalen (1a),6 methoxylated derivatives (1b-d) were 
selected as olefins for our study and can be easily obtained from 
the corresponding commercially available α-tetralones.15 Com-
mercially available o-iodophenol (3a) and its easily prepared p-
substituted derivatives 3b and 3c, bearing electron withdrawing 
NO2 and CO2Me, respectively, were obtained by iodination of the 
correspondig phenols.16 O-Iodophenol 3d, substituted by CHO and 
MeO groups, prepared by iodination of vanillin16 was considered 
as an option to install oxygenated groups at the D-ring, one of the 
limitations of this oxyarylation reaction.6   
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1. Oxyarylation of 1a with 3a. 
 
Table1. Optimizing the reaction conditions for the oxyarylation 
of 1a with 3a.  
   
En-
try 
Cond
[a]
 
Pd(mol%) solvent T 
(ºC) 
Time 
[b] 
Yield(%) 
[c]
 
1c A Pd(OAc)2 
(10) 
acetone 60d 40 min 58 
2 A Pd(OAc)2 
(10) 
PEG-
2000 
140 40 min 87 
3  A Pd(OAc)2 
(10) 
PEG-400 140 2 h 45 
4 A Pd(OAc)2 
(10) 
PEG-400 170 10 min 85 
5 A Pd(OAc)2 
(10) 
PEG-200 140 2 h - 
6 A Pd(OAc)2 
(5) 
PEG-400 170 10 min 82 
7c B palladacycl
e(1) 
DMA/H2
0 
120d 40 min 41 
8 B palladacycl
e (1) 
PEG-
2000 
140 3 h 80 
9 B  
palladacycl
e (1) 
PEG-400 140 3 h - 
10 B   
palladacycl
e ( 1) 
PEG-400 170 2 h 78 
a
 Reaction followed by GC. b Isolated yield. c See ref. 6. d Under microwave 
irradiation (40 W, 60ºC). Condition A: base is Ag2CO3 (1.1 equiv). Condi-
tion B: base is Cy2NH (2 equiv). 
Once the product isolation was easier in PEG-400 than in PEG-
2000, we decided to continue our study using this solvent. The 
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scope of the reaction was studied through the oxyarylation of dihy-
dronaphthalene and methoxylated derivatives (1a-d) with substi-
tuted o-iodophenols 3a-d, under the mentioned reaction conditions, 
A: Pd(OAc)2 (10 or 5 mol%), Ag2CO3 (1.1 equiv.), PEG-400, 140 
or 1700C and B: p-hydroxyacetophenone oxime-derived pallada-
cycle (1 mol%), Cy2NH (2 equiv.), PEG-400, 140 or 1700C 
(Scheme 2, Table 2).  
In Scheme 2, Table 2, are shown the results obtained for the oxya-
rylation of 1a with 3b-d. Using conditions A, the oxyarylation of 
1a with 3b and 3c led to 5ab and 5ac, respectively, in excellent 
yields (Table 2, entries 1 and 2) while good yield of 5ad  were 
obtained in the reactions with 3d (entry 3). Under conditions B, 
moderate to good yields were obtained (entries 4-6), in particular 
for electron poor o-iodophenols 3b and 3c (entries 4 and 5).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    Scheme 2. Oxyarylation of 1a-e with 3a-d. 
 
Table  2. Major conditions and yields for reaction shown 
in Scheme 2. 
 
Entry Cond[a] T(ºC) 1 3 5 Time      
(min)[b] 
Yield 
(%)[c] 
1 A 170 a b ab 30 91 
2 A 170 a c ac 5 91 
3 [d] A 170 a d ad 60 77 
4 B 170 a b ab 120 66 
5 B 170 a c ac 40 84 
6 B 170 a d ad 240 47c 
7 A 140 b a ba 10 (60)b 81 (85)b 
8 A 140 b b bb 10 (60)b 93 (89)b 
9 A 140 b c bc 15 (60)b 90 (88)b 
10 A 140 b d bd 30 (60)b 10 (60)b 
11 B 140 b a ba 120 70 (68)b 
12 B 140 b b bb 180 43 
13 B 140 b c bc 40 68 
14 B 140 b d bd 180 64 
15 A 140 c a ca 10 (40)b 80 (78)b 
16 A 140 c b cb 20 89 
17 A 140 c c cc 10 78 
18 A 140 c d cd 30 (60)b 70 (75)b 
19 B 140 c a ca 30 36 
20 B 140 c b cb 120 68 
21 B 140 c c cc 60 81 
22 B 140 c d cd 240 30 
23 A 140 d a da 5 80 
24 A 140 d b db 40 80 
25 A 140 d c dc 10 87 
26 A 140 d d dd 60 68 
27 B 140 d a da 40 30 
28 B 140 d b db 180 70 
29 B 140 d c dc 120 71 
30 B 140 d d dd 240 38 
 
aReaction followed by CG and yields of purified products. b5 mol% of 
Pd(OAc)2 was used in these cases.c PEG-2000 was used in this case. 
Conditions A: Pd(OAc)2 (10 mol%), Ag2CO3 (1.1 equiv.), PEG-400; Condi-
tions B: Palladacycle  (1 mol%), Cy2NH (2 equiv.), PEG-400. 
 
When 5-methoxydihydronaphthalene (1b) was allowed to react 
with o-iodophenol (3a) at 170ºC under Conditions A an extensive 
degradation was observed and only traces of adduct 5ba could be 
detected by GC. However, this compound was obtained in 81% and 
80% yields using 10 and 5 mol % of Pd(OAc)2, respectively, in 
only 10 min of reaction time by lowering the temperature to 140ºC 
(Table 2, entry 7). Compounds 5bb, 5bc and 5bd were also ob-
tained by oxyarylation of 1b with 3b-d, in excellent yields, in 10 to 
30 min under Conditions A at 140 ºC (Table 2, entries 8-10). Essen-
tially the same yields were observed in the presence of 5 mol% of 
Pd(OAc)2, although the reaction time increase to 1h (entries 8-10).  
Using Conditions B (entries 11-14), adducts 5 were obtained from 
moderate to good yield.  
The same trend was also observed when 1c and 1d were oxyary-
lated with iodophenols  3a-d (Table 2, entries 15-30). Under Con-
ditions A (5 mol% Pd(OAc)2),  5ca to 5cd and 5da to 5dd were 
obtained in excellent yields (entries 15-18 and 23-36) in few mi-
nutes, at 140ºC. On the other hand, compounds 5ca and 5cd (en-
tries 19 and 22) as well as 5da and  5dd (entries 27 and 30) were 
obtained in moderate yields under Conditions B. However, prod-
ucts 5cb and 5cc (entries 20 and 21) as well as 5db and 5dc (en-
tries 28 and 29) were isolated good yields. 
Representative oxyarylation of 1a with 3a was scaled up to ~1g  
using conditions A, affording adduct 5aa with similar yield (82 
versus 72%). In addition, in this experiment Ag2CO3 was partially 
recuperated (70%) from the reaction medium, making the condi-
tions A more environmentally appropriate. The recovered Ag2CO3 
was used as base in other oxyarylations, leading to the adducts in 
essentially the same yield. 
Next we evaluated the synthesis of 6 by oxyarylation of 1a and 
1c,d with 3-iodolawsone (4) under conditions A. This reaction was 
discovered by da Silva and cols17,18 and due to promising anti-
neoplastic and anti-leishmanial activities, these compounds were 
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patented.17 In previously results obtained for the preparation of 6a 
from 1a, the best yield was obtained by the use of Ag2CO3 (1.5 eq) 
as base, 3-iodolawsone (4) (2 eq) and pinacolone as solvent under 
reflux for 18 hours (57% yield).17  In PEG-400 at 90 0C, the reac-
tion between 1a and 4 was faster (10 minutes), leading to adduct 6a 
in 53% chemical yield (Scheme 3, Table 3, entry 1). The carbapte-
rocarpanquinones 6b-d were obtained with similar yields (entries 
2-4). 
 
 
 
 
 
 
 
 
 
Scheme 3. Oxyarylation of 1 with 4. 
 
TABLE 3. Oxyarylation of 1a-d with 4 under conditions A. 
Entry Cond[a] T(ºC) 1 6 Time      
(min)[b] 
Yield 
(%)[c] 
       
1 A 90 a a 10 53 
2 A 90 b b 10 43 
3  A 90 c c 10 47 
4 A 90 d d 10 46 
a] Conditions A: Pd(OAc)2 (10 mol%), Ag2CO3 (1.1 equiv.), PEG-400. 
Finally, we studied the effect of PEG-400 on the oxyarylation of 
chromenquinone 2 with 3a-d (Table 4). The pterocarpanquinone 
7a (know as LQB-118) has in vitro and in vivo activities as anti-
cancer and antiparasitic.7 Using conditions A, 7a was obtained in 
58% yield  by the oxyarylation of 2 with 3a (Scheme 4, Table 4, 
entry 1). We get a improvment on yield of this oxyarylation com-
pared to the first synthesis of 7a in acetone as solvent under reflux 
(40 % yield).7d When 2 was oxyarilated with 3b-c, the yields of 
7b,c were lower, as in acetone (Scheme 4, Table 4, entries 2-4, 6), 
but the yield of  7d increase from 14 to 30%. 
 
 
Scheme 4. Oxyarylation of 2 with 3a-d. 
 
 
Table 4. Major conditions and yield for reactions of Scheme 3. 
Entry Cond[a] T(ºC) 3  7  Time      
(min)[b] 
Yield 
(%)[c] 
1 A 90 3a 7a 10 58 
2 A 90 3b 7b 10  11 
3  A 90 3c 7c 10  23 
4 A 90 3d 7d     10  30 
 [a] Conditions A: Pd(OAc)2 (10 mol%), Ag2CO3 (1.1 equiv.), PEG-400. 
 
Due the biological relevance of 7a,7 we scale up the synthesize of 
this compound. The oxyarilation of 14 mmol of 2 with 3a (1.5 eq) 
furnished 2.5 g (58% yield) of 7a after 30 min. of reaction under 
Conditions A at 90ºC. 
Conclusion  
PEG-400 was employed for the first time as solvent in oxyary-
lation reactions. Once this solvent is neither volatile nor toxic, 
having several applications in medicine,19 it is possible to work 
safely at higher temperatures. PEG-400 quickly reduce PdII from 
Pd(OAc)2 or p-hydroxyacetophenone oxime-derived palladacycle 
to Pd0 and the oxyarylations do not require the use of ligands. The 
oxyarylations of electron rich olefins (dihydronaphthalens 1a-d) 
with o-iodophenols (2a-d), using Pd(OAc)2 (5-10 mol %) as pre-
catalyst and Ag2CO3 (1.1 equiv.) as base at 140 or 170 ºC, are very 
fast (5-30 min), leading to adducts in good to excellent chemical 
yields and complete regio- and stereoselectivity, in spite of the 
pattern of substitution in the synthetic precursors. Alternatively, for 
the oxyarylations involving o-iodophenol and more activated p-
nitro and p-carbomethoxy-o-iodophenols, the use of 4-
hydroxyacetophenone oxime-derived palladacycle (1 mol %) as 
pre-catalyst and dicyclohexylamine (2 equiv.) as base in PEG-400 
at 140 ºC led to products in good yields, using a low catalytic load 
(1 mol%) in the absence of Ag2CO3.  
Dihydronaphthalens (1a-d) also reacts fast with 3-iodolawsone 
4, leading to carbapterocarpanquinones 6a-d in moderated yield. 
In contrast with 1a-d, electron poor olefin 2 reacts with o-
iodophenols substituted by electron withdrawing groups leading to 
adducts in poor yields. However, reasonable yields are obtained 
with o-iodophenol (3a). In addition, products obtained in the reac-
tions performed in acetone under MW heating need to be carefully 
purified by chromathography in silica gel while those obtained in 
PEG-400 required just a filtration in a pad of silica gel.  
 
Experimental   
 
General Experimental Section. 1H and 13C NMR spectra were 
recorded in CDCl3 on 400 MHz NMR spectrometer using TMS as 
internal standard. Low-resolution electron impact (GC-EI) mass 
spectra were obtained at 70 eV using a Shimadzu QP-5000, and 
HRMS (GC-EI) were recorded using a Finnigan MAT 95S instru-
ment. Analytical TLC was performed using Schleicher & Schuell 
F1400/LS silica gel plates, and the spots were visualized under UV 
light (λ=254 nm). Melting points were determined with a Fisatom 
430 apparatus and are uncorrected. For flash chromatography, we 
employed Merck silica gel 60 (0.040–0.063 mm). 
General Procedure for Oxyarylation Reactions  
Conditions A: A mixture of the selected dihydronaphthalenes 1a-d 
(0.5 mmol), o-iodophenols 3a-d (1.0 mmol), Pd(OAc)2 (5-10 
mol%), Ag2CO3 (1.1 equiv.) and PEG-400 (2.0 mL) was heated  (in 
a flask under magnetic stirring at the temperature indicated in 
Tables 1 and 2. After the reaction time indicated, the mixture was 
cooled to rt and it was filtered through a pad of celite, using ethyl 
acetate (15 mL) as solvent. The organic layer was washed with 
distilled water (1 x 5 mL) and brine (3 x 5 mL), dried over anhydr-
ous sodium sulfate and filtered. The solvent was evaporated in 
vacuo and the resulting oils were purified by flash chromatography 
on silica gel (3% AcOEt/hexane as eluent), leading to pure prod-
ucts 5.  
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In one experiment 1a (0.988 g, 7.26 mmol) was oxyarylated with 
3a (3.194 g, 14.52 mmol, 0.5 mol%) in Conditions A, using 
Pd(OAc)2 (81.46 mg, 0.36 mmol). Compound 5aa was obtained as 
a viscous oil in 72% yield (1.203 g). In this experiment the reaction 
was passed through a filter paper and the filtrate was washed with 
ethyl acetate (50 mL). The solution was treated as described above. 
The solid was washed with HNO3 10M (20mL), NaHCO3 (2 x 
20mL), H2O (2 x 20mL) and dried under vacuum, leading to re-
covered Ag2CO3 (1.541 g, 70%). This recovered Ag2CO3 was used 
in other oxyarylations, leading to products in similar chemical 
yields. 
 
Conditions B: A mixture of the selected dihydronaphthalenes 1a-d 
(0.5 mmol), o-iodophenols 3a-d (1.0 mmol), palladacycle (1 
mol%), Cy2NH (2.0 equiv.) and PEG-400 (2 mL) was heated in a 
flask under magnetic stirring at the temperature indicated in Tables 
1 and 2. The reaction was worked-up as above.  
6aR*,11aS*)-4-Methoxy-5,6,6a,11a-tetrahydronaphtho[1,2-
b]benzofuran (5ba): 1H NMR (400 MHz, CDCl3) δ: 1.78 – 1.68 
(m, 1H), 2.13 – 1.98 (m, 1H), 2.61 – 2.49 (m, 1H),  2.84 – 2.71 (m, 
1H), 3.66 – 3.55 (m, 1H), 3.82 (s, 3H), 5.63 (d, J = 8.2 Hz, 1H), 
6.91 – 6.77 (m, 3H),  7.12 (t, J = 8.1 Hz, 1H), 7.20 (d, J = 7.4 Hz, 
1H),   7.26 (dd, J = 13.6, 5.7 Hz, 2H); 13C NMR (101 MHz, 
CDCl3) δ: , 20.33, 26.97, 40.81, 55.61, 81.66, 109.57, 109.69, 
120.59, 122.29, 124.34, 127.02, 127.65, 128.32, 131.90, 134.38, 
156.51, 159.19. 
 (6aR*,11aS*)-4-Methoxy-8-nitro-5,6,6a,11a-
tetrahydronaphtho[1,2-b]benzofuran (5bb): 1H NMR (400 
MHz, CDCl3) δ: 8.14 (s, 1H), 8.09 (dd, J = 8.8, 1.8 Hz, 1H), 7.28 
(dd, J = 14.7, 6.7 Hz, 1H), 7.16 (d, J = 7.7 Hz, 1H), 6.85 (d, J = 8.1 
Hz, 1H), 6.79 (d, J = 8.8 Hz, 1H), 5.83 (d, J = 8.5 Hz, 1H), 3.82 (s, 
3H), 3.74 (m, 1H), 2.79 – 2.56 (m, 2H), 2.10 (m, 1H), 1.78 (m, 
1H); 13C NMR (101 MHz, CDCl3) δ: 164.77, 156.46, 142.01, 
133.05, 127.40, 127.34,  127.15,  125.97,  122.03,  120.79,  110.02,  
109.46, 84.14, 55.47,  40.07,  26.78, 19.78. 
Methyl(6aR*,11aS*)-4-methoxy-5,6,6a,11a-
tetrahydronaphtho[1,2-b]benzofuran-8-carboxylate (5bc): 1H 
NMR (500 MHz, CDCl3) δ: 1.81- 1.73 (m, 1H), 2.13 – 2.04 (m, 
1H), 2.63 – 2.55 (m, 1H), 2.75 – 2.69 (m, 1H), 3.70 - 3.65 (m, 1H),  
3.81 (s, 3H), 3.88 (s, 3H),  5.74 (d, J = 8.4 Hz, 1H), 6.78 (d, J = 8.4 
Hz, 1H), 6.83 (d, J = 7.8 Hz, 1H), 7.17 (d, J = 7.6 Hz, 1H),  7.29 – 
7.24 (m, 1H),  7.88 (dd, J = 8.4, 1.8 Hz, 1H), 7.94 (s, 1H); 13C 
NMR (101 MHz, CDCl3) δ:167.06, 163.47, 156.53, 133.78, 
131.99, 127.52, 127.10, 126.20, 122.81, 122.12, 109.76, 109.44, 
83.04, 55.58, 51.86, 40.14, 26.87, 19.91. 
(6aR*,11aS*)-4,10-Dimethoxy-5,6,6a,11a-
tetrahydronaphtho[1,2-b]benzofuran-8-carbaldehyde (5bd): 1H 
NMR (400 MHz, CDCl3) δ: 1.77 - 1.85 (m, 1H), 2.13 – 2.00 (m, 
1H), 2.76 – 2.54 (m, 2H),  3.75 (m, 1H), 3.81 (s, 3H),  3.90 (s, 3H),  
5.85 (d, J = 8.6 Hz, 1H), 6.83 (dd, J = 6.5, 2.6 Hz, 1H), 7.25 (dd, J 
= 6.8, 2.7 Hz, 2H), 7.31 (d, J = 0.9 Hz, 1H), 7.43 (s, 1H),  9.83 (s, 
1H); 13C NMR (101 MHz, CDCl) δ:190.62,156.30, 153.63, 19.80, 
145.00, 133.46, 133.21, 133.11, 131.27, 127.03, 122.54, 120.78, 
111.61, 109.94, 84.20, 55.99, 55.49, 40.44, 26.85.       
(6aR*,11aS*)-3-Methoxy-5,6,6a,11a-tetrahydronaphtho[1,2-
b]benzofuran (5ca): 1H NMR (400 MHz, CDCl3) δ: 1.87 – 1.79 
(m, 1H), 2.02 – 1.98 (m, 1H), 2.72 – 2.55 (m, 2H), 3.65 – 3.63 
(m,1H), 3.79 (s, 3H), 5.64 (d, J = 8.4 Hz, 1H), 6.67 (d, J = 2.2 Hz, 
1H), 6.76 (d, J = 8.0 Hz, 1H),  6.90 – 6.81 (m, 2H), 7.11 (td, J = 
7.8, 1.0 Hz, 1H),  7.22 (d, J = 7.3 Hz, 1H), 7.45 (d, J = 8.4 Hz, 
1H); 13C NMR (101 MHz, CDCl3) δ: 159.44, 159.42, 140.54, 
131.50, 131.38, 128.27, 125.75, 124.35, 120.47, 113.30, 112.60, 
109.53, 81.78, 55.27, 41.03, 28.08, 27.83. 
 (6aR*,11aS*)-3-Methoxy-8-nitro-5,6,6a,11a-
tetrahydronaphtho[1,2-b]benzofuran (5cb): 1H NMR (400 MHz, 
CDCl3) δ: 8.14 (s, 1H), 8.10 (d, J = 2.1 Hz, 1H), 7.44 (d, J = 8.5 
Hz, 2H), 6.86 (dd, J = 8.4, 2.6 Hz, 2H), 6.78 (d, J = 8.7 Hz, 2H), 
6.69 (d, J = 2.3 Hz, 2H), 5.87 (d, J = 8.7 Hz, 2H), 3.81 (s, 3H), 
3.79 – 3.76 (m, 1H), 2.67 – 2.64 (m, 2H), 2.15 – 2.05 (m, 1H), 1.90 
– 1.86 (m, 1H); 13C NMR (101 MHz, CDCl3) δ: 165.04, 159.82, 
141.91, 140.38, 132.83, 131.54, 126.04, 124.20, 120.92, 113.37, 
112.91, 109.32, 84.41, 55.31, 40.20, 27.92, 27.33. 
Methyl(6aR*,11aS*)-3-methoxy-5,6,6a,11a-
tetrahydronaphtho[1,2-b]benzofuran-8-carboxylate (5cc): 1H 
NMR (400 MHz, CDCl33) δ 7.93 (s, 1H), 7.88 (dd, J = 8.4, 1.7 Hz, 
1H), 7.44 (d, J = 8.4 Hz, 1H), 6.85 (dd, J = 8.4, 2.6 Hz, 1H), 6.76 
(d, J = 8.4 Hz, 1H), 6.68 (d, J = 2.5 Hz, 1H), 5.77 (d, J = 8.6 Hz, 
1H), 3.89 (s, 3H), 3.80 (s, 3H), 3.79 – 3.70 (m, 1H), 2.70 – 2.57 
(m, 2H), 2.13 – 2.00 (m, 1H), 2.1 - 1.90 (m,1H); 13C NMR (101 
MHz, CDCl3) δ: 157.76, 157.39, 142.80, 138.87, 133.04, 131.26, 
129.19, 127.87, 127.14, 126.84, 118.58, 113.15, 112.05, 105.70, 
55.14, 53.66, 44.87, 30.16, 29.77. 
(6aR*,11aS*)-3,10-Dimethoxy-5,6,6a,11a-
tetrahydronaphtho[1,2-b]benzofuran-8-carbaldehyde (5cd):1H 
NMR (400 MHz, CDCl3) δ: 1.99 – 1.86 (m, 1H), 2.12 - 2.06 (m, 
1H), 2.76 – 2.52 (m, 2H), 3.56 – 3.44 (m, 1H), 3.80 (s, 3H), 3.90 
(s, 3H),    5.90 (d, J = 8.8 Hz, 1H), 6.67 (d, J = 2.6 Hz, 1H), 6.84 
(dd, J = 8.4, 2.7 Hz, 1H), 7.26 (s, 1H), 7.42 (s, 1H), 7.50 (d, J = 8.5 
Hz, 1H), 9.83 (s, 1H); 13C NMR (101 MHz, CDCl3) δ: 190.91, 
159.95, 154.38, 145.01, 141.12, 132.78, 132.08, 131.83, 131.42, 
124.46, 120.62, 113.26, 112.55, 111.57, 84.41, 55.84, 55.15, 28.01, 
27.34. 
(6aR*,11aS*)-2-Methoxy-5,6,6a,11a-tetrahydronaphtho[1,2-
b]benzofuran (5da):1H NMR (400 MHz, CDCl3) δ 7.25 – 7.22 
(m, 1H), 7.15 – 7.02 (m, 3H), 6.92 – 6.77 (m, 3H), 5.62 (d, J = 8.5 
Hz, 1H), 3.83 (s, 3H), 3.68 – 3.62 (m, 1H), 2.68 – 2.53 (m, 2H), 
2.10 – 1.99 (m, 1H), 1.78 – 1,73 (m, 1H); 13C NMR (101 MHz, 
CDCl3) δ: 159.21, 158.34, 134.31, 131.39, 130.78, 129.50, 128.27, 
124.31, 120.51, 114.88, 114.45, 109.66, 82.11, 55.36, 41.18, 28.43, 
26.79. 
 (6aR*,11aS*)-2-Methoxy-8-nitro-5,6,6a,11a-
tetrahydronaphtho[1,2-b]benzofuran (5db):1H NMR (400 MHz, 
CDCl3) δ: 8.14 (s, 1H), 8.10 (d, J = 2.4 Hz, 1H), 7.10 (s, 1H), 7.08 
– 7.04 (m, 1H), 6.86 (dd, J = 8.4, 2.7 Hz, 1H), 6.81 (d, J = 8.7 Hz, 
1H), 5.83 (d, J = 8.7 Hz, 1H), 3.84 (s, 3H), 3.84 – 3.75 (m, 1H), 
2.69 – 2.59 (m, 2H), 2.22 – 2.07 (m, 1H), 1.90 – 1.77 (m, 1H); 13C 
NMR (101 MHz, CDCl3) δ: 165.13, 158.85, 142.16, 133.15, 
131.03, 130.01, 129.51, 126.17, 120.92, 115.34, 114.35, 109.48, 
85.11, 55.16, 39.88, 28.04, 26.64. 
Methyl(6aR*,11aS*)-2-methoxy-5,6,6a,11a-
tetrahydronaphtho[1,2-b]benzofuran-8-carboxylate (5dc): 1H 
NMR (400 MHz, CDCl3) δ: 1.82 – 1.77 (m, 1H), 2.15 – 2.00 (m, 
1H), 2.68 – 2.51 (m, 2H), 3.75 – 3.69 (m,1H), 3.84 (s, 3H), 3.88 (s, 
3H), 5.73 (d, J = 8.7 Hz, 1H), 6.78 (d, J = 8.4 Hz, 1H), 6.84 (dd, J 
= 8.4, 2.3 Hz, 1H), 7.06 (d, J = 8.5 Hz, 2H), 7.88 (d, J = 8.5 Hz, 
1H), 7.94 (s, 1H); 13C NMR (101 MHz, CDCl3) δ: 166.98, 163.40, 
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158.27, 133.55, 131.74, 131.30, 130.84, 129.48, 126.29, 122.92, 
115.11, 109.23, 83.21, 55.38, 51.87, 40.38, 28.08, 26.48. 
(6aR*,11aS*)-2,10-Dimethoxy-5,6,6a,11a-
tetrahydronaphtho[1,2-b]benzofuran-8-carbaldehyde (5dd): 1H 
NMR (400 MHz, CDCl3) δ: 9.83 (s, 1H), 7.42 (t, J = 3.6 Hz, 1H), 
7.13 (d, J = 2.5 Hz, 1H), 7.06 (d, J = 8.4 Hz, 1H), 6.84 (dd, J = 8.4, 
2.6 Hz, 1H), 5.84 (d, J = 11.0 Hz, 1H), 3.91 (s, 3H), 3.83 (s, 3H), 
3.81 - 3.78 (m, 1H), 2.66 – 2.56 (m, 2H), 2.15 – 2.05 (m, 1H), 1.95 
– 1.44 (m, 1H); 13C NMR (101 MHz, CDCl3) δ: 190.85, 158.36, 
153.82, 144.87, 133.00, 132.83, 131.42, 131.17, 130.79, 129.38, 
120.89, 115.39, 114.59, 111.54, 84.54, 55.91, 55.53, 28.07, 26.34. 
 
Oxy-arylation of dihydronaphthalens with 3-iodolawsone un-
der Conditions A.  
A mixture of the selected dihydronaphthalenes 1a-d (0.5 mmol), o-
3-iodolawsone 4 (1.0 mmol), Pd(OAc)2 (10 mol%), Ag2CO3 (1.1 
equiv.) and PEG-400 (4.0 mL) was heated  (in a flask under mag-
netic stirring at 900C for 10 min.. After the mixture was cooled to rt 
and it was filtered through a pad of celite, using ethyl acetate (35 
mL) as solvent. The organic layer was washed with brine (3 x 50 
mL), dried over anhydrous sodium sulfate and filtered. The solvent 
was evaporated in vacuo and the resulting oils were purified by 
flash chromatography on silica gel (5% AcOEt/hexane as eluent), 
leading to pure products 6a-d.  
(6aR*,13aS*)-6,6a-dihydrodinaphtho[1,2-b:2',3'-d]furan-
7,12(5H,13aH)-dione (6a): 1H NMR (400 MHz, CDCl3) δ 8.09 
(td, J = 7.5, 1.1 Hz, 2H), 7.74 (td, J = 7.5, 1.4 Hz, 1H), 7.68 (td, J = 
7.5, 1.4 Hz, 1H), 7.59 (dd, J = 5.2, 3.8 Hz, 1H), 7.31 (dd, J = 5.6, 
3.4 Hz, 2H), 7.22 – 7.16 (m, 1H), 5.92 (d, J = 9.8 Hz, 1H), 3.94 (dt, 
J = 9.7, 7.0 Hz, 1H), 2.77 (ddd, J = 15.4, 8.4, 3.9 Hz, 1H), 2.67 
(ddd, J = 15.7, 8.0, 3.8 Hz, 1H), 2.24 – 2.13 (m, 1H), 2.02 (tdd, J = 
11.7, 7.7, 3.9 Hz, 1H). 
(6aR*,13aS*)-4-methoxy-6,6a-dihydrodinaphtho[1,2-b:2',3'-
d]furan-7,12(5H,13aH)-dione (6b): 1H NMR (400 MHz, cdcl3) δ 
8.00 (ddd, J = 8.9, 7.7, 1.2 Hz, 1H), 7.65 (td, J = 7.5, 1.5 Hz, 1H), 
7.59 (td, J = 7.5, 1.5 Hz, 1H), 7.24 – 7.07 (m, 1H), 6.78 (dd, J = 
7.9, 1.2 Hz, 1H), 5.79 (d, J = 9.5 Hz, 1H), 3.83 – 3.77 (m, 1H), 
3.74 (s, 1H), 2.71 (ddd, J = 16.5, 7.4, 4.0 Hz, 1H), 2.53 (ddd, J = 
16.6, 8.8, 4.0 Hz, 1H), 2.14 – 2.07 (m, 1H), 1.88 – 1.78 (m, 1H). 
13C NMR (101 MHz, cdcl3) δ 182.39, 177.99, 160.01, 156.30, 
134.12, 133.15, 132.92, 131.90, 127.99, 127.09, 126.28, 125.95, 
122.47, 120.50, 110.30, 108.62, 84.73, 55.53, 39.56, 24.75, 19.76. 
 
(6aR*,13aS*)-3-methoxy-6,6a-dihydrodinaphtho[1,2-b:2',3'-
d]furan-7,12(5H,13aH)-dione (6c): 1H NMR (400 MHz, CDCl3) 
δ 8.08 (t, J = 7.7 Hz, 2H), 7.76 – 7.71 (m, 1H), 7.70 – 7.64 (m, 
1H), 7.48 (d, J = 8.5 Hz, 1H), 6.84 (dd, J = 8.4, 2.5 Hz, 1H), 6.70 
(d, J = 2.2 Hz, 1H), 5.91 (d, J = 9.7 Hz, 1H), 3.91 (dt, J = 9.7, 6.3 
Hz, 1H), 3.81 (s, 3H), 2.80 – 2.68 (m, 1H), 2.63 (ddd, J = 11.9, 7.0, 
4.3 Hz, 1H), 2.19 – 2.02 (m, 2H); 13C NMR (101 MHz, cdcl3) δ 
182.42, 178.03, 160.30, 159.98, 141.20, 134.14, 133.18, 132.92, 
132.05, 131.45, 130.23, 126.29, 125.93, 123.21, 113.39, 112.64, 
85.27, 55.29, 39.72, 27.46, 25.49. 
(6aR*,13aS*)-2-methoxy-6,6a-dihydrodinaphtho[1,2-b:2',3'-
d]furan-7,12(5H,13aH)-dione (6d): 1H NMR (400 MHz, cdcl3) δ 
8.09 (ddd, J = 7.2, 5.7, 1.3 Hz, 2H), 7.74 (td, J = 7.5, 1.4 Hz, 1H), 
7.68 (td, J = 7.5, 1.4 Hz, 1H), 7.12 (d, J = 2.7 Hz, 1H), 7.09 (d, J = 
8.4 Hz, 1H), 6.87 (dd, J = 8.4, 2.7 Hz, 1H), 5.87 (d, J = 9.7 Hz, 
1H), 3.90 (ddd, J = 9.7, 7.7, 5.7 Hz, 1H), 3.84 (s, 3H), 2.71 (ddd, J 
= 15.5, 8.0, 3.8 Hz, 1H), 2.65 – 2.56 (m, 1H), 2.25 – 2.14 (m, 1H), 
2.02 – 1.91 (m, 1H); 13C NMR (101 MHz, cdcl3) δ 182.37, 177.99, 
160.00, 158.34, 134.17, 133.14, 132.96, 131.73, 131.45, 131.16, 
129.48, 126.85, 126.31, 125.97, 115.78, 114.51, 84.96, 55.46, 
39.83, 26.49, 25.71. 
 
Oxy-arylation of chromenquinone (2) with o-iodonaphenols 
(3a-d)  under Condition A.  
A mixture of chromenequinone (2) (0.5 mmol), o-iodophenol (3a-
d) (0.75 mmol), Pd(OAc)2 (10 mol%), Ag2CO3 (1.1 equiv.) and 
PEG-400 (4.0 mL) was heated  (in a flask under magnetic stirring 
at 900C for 10 min.. After the mixture was cooled to rt and it was 
filtered through a pad of celite, using ethyl acetate (35 mL) as 
solvent. The organic layer was washed with brine (3 x 50 mL), 
dried over anhydrous sodium sulfate and filtered. The solvent was 
evaporated in vacuo and the resulting oils were purified by flash 
chromatography on silica gel (20% AcOEt/hexane as eluent), 
leading to pure products 7a-e and 9. 
(7aS*,12aS*)-7,7a-dihydro-5H-benzo[g]benzofuro[3,2-
c]chromene-5,13(12aH)-dione (7a): 1H NMR (400 MHz, cdcl3) δ 
8.17 (dd, J = 7.6, 1.1 Hz, 1H), 8.11 (dd, J = 7.6, 1.3 Hz, 1H), 7.78 
(td, J = 7.5, 1.5 Hz, 1H), 7.72 (td, J = 7.5, 1.4 Hz, 1H), 7.27 (dd, J 
= 7.1, 3.0 Hz, 1H), 7.21 (t, J = 7.8 Hz, 1H), 6.93 (td, J = 6.7, 3.0 
Hz, 2H), 5.65 (d, J = 6.7 Hz, 1H), 4.58 (ddd, J = 11.3, 5.3, 0.8 Hz, 
1H), 3.79 (t, J = 11.2 Hz, 1H), 3.61 – 3.54 (m, 1H); 13C NMR (50 
MHz, cdcl3) δ 183.25, 179.28, 158.73, 157.01, 134.55, 133.38, 
131.86, 130.57, 129.58, 126.49, 126.42, 125.11, 124.50, 121.23, 
118.14, 110.79, 72.31, 67.09, 38.38. 
(7aS*,12aS*)-9-nitro-7,7a-dihydro-5H-benzo[g]benzofuro[3,2-
c]chromene-5,13(12aH)-dione (7b): 1H NMR (300 MHz, CDCl3) 
δ 8.29 – 8.10 (m, 4H), 7.80 (tt, J = 8.9, 6.6 Hz, 2H), 7.01 (d, J = 
9.6 Hz, 1H), 5.89 (d, J = 7.0 Hz, 1H), 4.65 (dd, J = 11.3, 5.1 Hz, 
1H), 3.97 – 3.83 (t, J= 11.0 Hz, 1H), 3.83 – 3.70 (m, 1H); 13C 
NMR (101 MHz, ) δ 179.02, 164.18, 157.43, 142.58, 134.96, 
133.88, 131.84, 130.72, 127.21, 126.83, 126.78, 121.23, 117.26, 
110.94, 74.75, 66.61, 38.08, 29.72. 
(7aS*,12aS*)-methyl-5,13-dioxo-7,7a,12a,13-tetrahydro-5H-
benzo[g]benzofuro[3,2-c]chromene-9-carboxylate (7c):1H NMR 
(400 MHz, CDCl3), δ (ppm): 8.21–8.13 (2H, m); 7.99 (1H, s); 7.97 
(1H, d, J = 8.6 Hz); 7.82–7.73 (2H, m); 6.95 (1H, d, J = 8.3 Hz); 
5.77 (1H, d, J = 6.8 Hz); 4.61 (1H, dd, J = 5.1, 11.3 Hz); 3.89 (3H, 
s); 3.82 (1H, t, J = 11.0 Hz); 3.68–3.63 (1H, m). 
(7aS*,12aS*)-11-methoxy-5,13-dioxo-7,7a,12a,13-tetrahydro-
5H-benzo[g]benzofuro[3,2-c]chromene-9-carbaldehyde (7d): 
1H NMR (400 MHz, cdcl3) δ 9.86 (s, 1H), 8.20 (dd, J = 7.5, 1.1 Hz, 
1H), 8.15 (dd, J = 7.6, 1.2 Hz, 1H), 7.81 (td, J = 7.5, 1.5 Hz, 1H), 
7.75 (td, J = 7.5, 1.5 Hz, 1H), 7.47 (d, J = 0.8 Hz, 1H), 7.41 (d, J = 
1.4 Hz, 1H), 5.86 (dd, J = 6.8, 0.7 Hz, 1H), 4.64 (ddd, J = 11.3, 5.2, 
0.8 Hz, 1H), 3.94 (s, 3H), 3.84 (t, J = 11.2 Hz, 1H), 3.73 – 3.66 (m, 
1H); 13C NMR (101 MHz, acetone) δ 184.97, 177.57, 173.99, 
151.95, 147.81, 140.55, 129.62, 128.40, 126.72, 126.71, 125.42, 
122.01, 121.47, 121.43, 115.14, 112.25, 107.91, 69.24, 61.70, 
50.84, 33.03. 
Scale up of pterocarpanquinone 7a: (LQB-118) 
A mixture of chromenequinone (2) (2.97 g, 14 mmol), o-
iodophenol (3a) (3.7 g, 16.8 mmol), Pd(OAc)2 (314.3 mg, 1.4 
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mmol, 10 mol%), Ag2CO3 (4.25 g, 15.4 mmols, 1.1 equiv.) and 
PEG-400 (100.0 mL) was heated  in a flask under magnetic stirring 
at 900C for 30 min.. After the mixture was cooled to rt and it was 
filtered through a pad of celite, using ethyl acetate (250 mL) as 
solvent. The organic layer was washed with brine (3 x 150 mL), 
dried over anhydrous sodium sulfate and filtered. The solvent was 
evaporated in vacuo and the resulting oil was purified by flash 
chromatography on silica gel (125g) (30% AcOEt/hexane as elu-
ent), leading to 2.5 g (8.1 mmol) of 7a in 58% yield . 
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